Recent Articles from Investor Brand Network

As the cannabis sector continues to expand, universities and colleges across the U.S. are adjusting their academic offerings to keep pace with a growing need for trained professionals. The industry currently supports an estimated 425,000 full-time positions nationwide.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Olenox Industries (NASDAQ: OLOX) announced stockholders approved multiple corporate actions at its March 31, 2026 annual meeting, including the election of directors, ratification of its independent auditor, executive compensation on an advisory basis, several share issuance proposals and amendments to increase authorized shares and expand the company’s stock incentive plan. Stockholders also approved a potential reverse stock split at a ratio between 1-for-10 and 1-for-20, while rejecting the proposed merger agreement with New Asia Holdings and related preferred stock conversion.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Electric vehicle manufacturers are constantly seeking ways to boost how far their models can go on a single charge, and a French tire maker has just come up with new tires that they say can boost EV range.

Cybersecurity shares fell sharply on March 27 after reports surfaced that Anthropic is testing a new AI system with advanced cyber capabilities and possible security concerns.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Gold and silver prices moved higher in early trading at the start of the week. This comes as investors continue to purchase these precious metals in a bid to safeguard their wealth as the conflict in the Middle East rages on. This is typical in times of uncertainty when individuals turn to safe-haven assets like gold.

Solar power has surged from supplying 1% of global electricity in 2015 to roughly 10% today, outpacing nuclear generation and growing faster than any other energy source this century. Worldwide capacity reached approximately 2,900 gigawatts in 2025, and if current expansion rates continue, installations could hit 9,000 gigawatts by 2030, meeting over 20% of planetary energy demand.

Used electric vehicles are suddenly the most searched category in Australia’s second-hand car market, and the timing is no coincidence. Fuel costs have crossed thresholds that are genuinely changing purchase behavior. The used EV segment was already building momentum well before prices at the pump became a daily grievance . Pickles, one of the country’s largest automotive auction platforms, has seen triple-digit growth in EV-related searches over the past month alone.

The crypto market is holding near a $2.32 trillion market cap, showing little change compared with last week. That stability stands out at a time when traditional equities have struggled, with the Nasdaq-100 shedding roughly 5% over the same period.

A recently published report by Mordor Intelligence analyzes future projections, growth drivers and the key trends that are shaping the rapidly growing market for cancer immunotherapy. The report puts the valuation of this market in 2025 at $144.8 billion and projects that it will expand to $311.4 billion by 2031.

The ongoing Iran war has led many AI industry watchers and investors to start getting concerned about whether this conflict could push the industry over the edge and cause what many call “ the AI bubble ” to burst. Several developments have led these grim predictions to seem credible to many.

A recent survey has revealed a major gap in how cryptocurrency users understand taxes, raising concerns about compliance and the future growth of the industry. The report, conducted by Coinbase in partnership with CoinTracker, shows that many investors are still confused about basic tax rules related to digital assets.

Large-scale layoffs in the technology sector are no longer unusual. What has shifted is how company leaders explain them. In previous years, executives often blamed restructuring efforts on excessive hiring, bloated management structures, or a push for efficiency. Now, a different theme dominates. AI has become the central explanation for why companies are trimming their workforce.

Olenox Industries (NASDAQ: OLOX) announced stockholders approved multiple corporate actions at its March 31, 2026 annual meeting, including the election of directors, ratification of its independent auditor, executive compensation on an advisory basis, several share issuance proposals and amendments to increase authorized shares and expand the company’s stock incentive plan. Stockholders also approved a potential reverse stock split at a ratio between 1-for-10 and 1-for-20, while rejecting the proposed merger agreement with New Asia Holdings and related preferred stock conversion.

Oncotelic Therapeutics (OTCQB: OTLC) announced a strategic partnership with TechForce Robotics to advance commercialization of its PDAOAI-enabled, GMP-compliant robotics platform designed for pharmaceutical manufacturing and regulated environments. The integrated system combines Oncotelic’s proprietary AI capabilities with TechForce’s robotics and manufacturing expertise to enable automated material handling, real-time monitoring and compliance workflows, with scalability for broader deployment, as the companies move forward under a joint development, manufacturing and licensing agreement to address growing demand for intelligent, compliant automation solutions.

Xeriant (OTCQB: XERI) announced the U.S. Patent and Trademark Office has issued a Notice of Allowance for its patent covering a proprietary multilayered fire-resistant composite and manufacturing method, marking a key milestone for its DUREVER(TM) materials platform. The technology, featured in NEXBOARD(TM) composite wallboard, is advancing toward certification testing and is designed to deliver enhanced fire resistance, strength and sustainability across multiple industries, while the company also pursues international patent protection and expands its intellectual property and branding strategy.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

Wheaton Precious Metals Corp. (WPM) This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse reactions, supporting HyBryte’s potential as a well-tolerated therapy for early-stage CTCL.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

This article has been disseminated on behalf of NurExone Biologic and may include paid advertising.

American Fusion (OTC: AMFN) reported it is in the final stages of securing multi-year supply agreements with a U.S.-based subsidiary of a global industrial organization for helium-3 and deuterium, key fuels for its Texatron aneutronic fusion system. The proposed framework is expected to strengthen the company’s long-term commercialization strategy by establishing reliable access to critical inputs, while supporting parallel efforts across technology development, regulatory planning and supply chain buildout as it advances toward initial unit deployment and broader market entry.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Lantern Pharma (NASDAQ: LTRN) announced it will host an investor, analyst and shareholder briefing on April 9, 2026, at 8:30 a.m. Eastern, featuring a live demonstration of withZeta.ai, described as the first multi-agentic AI co-scientist for rare cancer drug discovery, development and clinical trial design. The webcast will highlight the platform’s capabilities, commercial architecture, competitive positioning and revenue strategy, alongside an overview of the rare cancer market opportunity and Lantern’s growth roadmap, with participation from CEO Panna Sharma and Chief Scientific Officer Kishor Bhatia.

Lantern Pharma (NASDAQ: LTRN) announced it will host an investor, analyst and shareholder briefing on April 9, 2026, at 8:30 a.m. Eastern, featuring a live demonstration of withZeta.ai, described as the first multi-agentic AI co-scientist for rare cancer drug discovery, development and clinical trial design. The webcast will highlight the platform’s capabilities, commercial architecture, competitive positioning and revenue strategy, alongside an overview of the rare cancer market opportunity and Lantern’s growth roadmap, with participation from CEO Panna Sharma and Chief Scientific Officer Kishor Bhatia.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

Datavault AI (NASDAQ: DVLT), an AI-driven data monetization, RWA tokenization and Web 3.0 infrastructure company, and Demora Foundation announced a Technology Integration Agreement naming Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform, spanning Atlanta, Dallas and the New York Tri-State area. Under the agreement, Datavault AI will deploy its enterprise AI stack — Data Vault(R), DataValue(R), DataScore(R) and Information Data Exchange(R) Digital Twin — as the backbone of Demora Chain to score, value, credentialize and tokenize K-Entertainment assets including K-Pop concert revenues, K-Drama royalties, digital rights, K-Beauty brands and K-Food franchises, targeting a market supported by more than 200 million global Hallyu fans, more than $40 billion in annual economic impact and a tokenizable pipeline valued at more than $3 billion.

Mississippi Governor Tate Reeves has vetoed two measures aimed at broadening access to medical cannabis, even as he approved a separate measure to advance research into a psychedelic drug with potential therapeutic uses.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) (d.b.a. TechForce Robotics) is an emerging robotics company focused on deploying AI-Enhanced automation across multiple industries. The company recently completed a comprehensive intellectual property acquisition of the BIM-E Autonomous Beverage Robotics Platform. An article discussing this reads, “The transaction comes at a time when the broader AI-driven service robotics market is accelerating from prototype development, toward real-world, revenue generating deployment, particularly across the high-traffic public venues. This platform automates beverage dispensing in an efficient and reliable manner and is designed to reduce wait times and ease labor constraints in environments such as hotels, conventions and sports arenas.”

The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for rare diseases.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

Massimo Group (NASDAQ: MAMO) reported financial results for the fiscal year ended Dec. 31, 2025, highlighting a significant expansion in gross margin to approximately 37.5% from 29.7% in 2024, driven by product mix optimization and cost efficiencies. While revenue declined to $71.8 million as the company rebalanced dealer inventory and prioritized pricing discipline, Massimo maintained profitability with $1.5 million in net income and continued advancing operational initiatives aimed at supporting long-term, higher-margin growth.

Stocks of memory chip manufacturers fell sharply this week as new signals suggested that the global shortage of memory chips may begin to ease. The decline wiped out nearly $100 billion in market value across major U.S. companies, showing how sensitive the sector has become to changes in expectations around artificial intelligence.

Scientists have overcome production barriers that have plagued doxorubicin manufacturing since the 1970s by engineering bacteria that generate 180% more of the critical chemotherapy drug than current methods achieve. The breakthrough addresses molecular bottlenecks that forced pharmaceutical companies to rely on expensive, multi-step processes despite treating over one million cancer patients annually with the medication.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported audited financial results for the year ended Dec. 31, 2025, highlighting revenue growth driven by initial smart cart deployments, including $3.6 million in Q4 revenue and $7.9 million for the full year. The company reported $72.5 million in working capital and continued executing its $20 million share repurchase program, with $3.5 million completed to date, as it transitions toward scaled deployments and broader geographic expansion.

As the week gets to the mid-point, spot gold has been trading in a tight range around $4,500 an ounce as a firmer dollar, elevated yields on Treasuries and a hawkish Fed exert a drag on prices of the precious metal.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a framework agreement with a Tier-1 international company specializing in autonomous drone interception, including integration of its DefendAir Net Pod into the client’s new drone platform. The agreement includes a minimum purchase of 2,000 customized units and is expected to expand global deployment of ParaZero’s Counter-UAS solutions while enhancing drone interception capabilities.

Linkers Industries Limited (NASDAQ: LNKS) announced its board has approved a 1-for-250 reverse share split of its Class A and Class B ordinary shares, with post-split trading set to begin April 6, 2026, under the same ticker and a new CUSIP. The move, intended to support continued Nasdaq listing compliance, will proportionally adjust outstanding shares, par value and warrants, while maintaining shareholder ownership percentages aside from fractional share rounding.

Perpetuals.com (NASDAQ: PDC), a fintech company developing AI-powered trading products and prediction markets, announced that CEO Patrick Gruhn will deliver a presentation and participate in a live question-and-answer session with investors at the Emerging Growth Conference on April 1 at 12:35 p.m. Eastern Time. The free, online event will provide an overview of the company’s AI-driven trading infrastructure and its broader strategy ( https://ibn.fm/6FTub ). According to details released by the company, investors will be able to watch the presentation via live webcast through the conference portal ( https://EmergingGrowth.com ).

NanoViricides, Inc. (NYSE American: NNVC) announced that a Phase II clinical trial of its antiviral candidate NV-387 for the treatment of MPox is expected to begin soon in the Democratic Republic of Congo, with site preparation and staff training scheduled for early April 2026. The study, already approved by the DRC regulatory agency, will evaluate the safety and effectiveness of NV-387 against Clade I MPox, as the company advances regulatory development and seeks Orphan Drug Designation from the U.S. FDA.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Rail Vision (NASDAQ: RVSN) reported financial results for the second half and full year ended Dec. 31, 2025, citing revenue growth and continued operational progress as it expands its global footprint. The company advanced deployments with Israel Railways, secured follow-on orders in Latin America, expanded into Central America and launched a proof of concept in India, underscoring increasing adoption of its AI-powered railway safety and obstacle detection systems in a global rail market projected to reach $460 billion by the mid-2030s.

Safe Pro Group (NASDAQ: SPAI) announced it has received a contract modification to provide continued support for its AI Edge Processing solution under an existing subcontract with the U.S. Government, reinforcing ongoing deployment of its AI-enabled defense and situational awareness technologies. The award supports the company’s efforts to advance real-time data processing and threat detection capabilities in government-sponsored applications.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2025, outlining a year marked by leadership changes, clinical progress and strategic expansion. The company advanced development of its lead compound LB-100, expanded clinical trials with additional sites and increased enrollment, completed the acquisition of Liora Technologies Europe Ltd. to enhance its cancer treatment platform, and raised more than $11 million to strengthen its balance sheet, as it positions for continued growth and innovation in oncology.

Datavault AI (NASDAQ: DVLT) CEO Nate Bradley will present at a private investor roundtable on April 2, 2026, at The Mar-a-Lago Club in Palm Beach, Florida, marking his second invitation in two months amid growing institutional interest in the company’s data monetization, tokenization and AI-driven platform. The event builds on momentum from a February engagement where Datavault AI highlighted $49 million in fourth-quarter 2025 agreements and projected more than $30 million in fiscal 2025 revenue, as the company continues to position itself at the intersection of data ownership, verified credentialing and real-world asset tokenization.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, reported strong revenue growth and improving loan economics in its recently reported fourth-quarter 2025 results, highlighting a strategy that combines digital mortgage origination with new fee-based real-estate finance products. The fintech lender posted net revenue of $2.5 million in the fourth quarter, up 127% from the same period a year earlier and 8.3% sequentially. Mortgage originations reached $84.7 million, a 44% increase year over year ( https://ibn.fm/DqJaW ).

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.

The United States Army has introduced new recruitment rules that expand eligibility, allowing older applicants to join. Under the updated policy, individuals up to 42 years old can now enlist in active duty, the Army Reserve, and the Army National Guard. This marks a notable shift from the previous age limit of 35.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently finished its first full reporting period as the world’s largest Solana treasury. A recent article shares details from an announcement of the company’s fiscal first quarter 2026 operating and financial results, updates, milestones and future plans. “As of Dec. 31, 2025, Forward Industries has SOL holdings of over 6.9 million, and almost all of the company’s SOL is staked. (As of the end of 2025, the company has generated over 112,171 SOL in staking rewards.)…Since the company adopted the SOL treasury strategy, FWDI’s validator infrastructure has generated between 6.5% and 7.2% gross annual percentage yield before fees, which outperforms many peer validators.”

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed Joseph Gunnar & Co.’s upgrade of the company from Hold to Buy and raising of its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization. The piece reads, “‘We upgrade HeartBeam to a BUY and High-Risk rating with a raised price target of $4 (from $1), reflecting progress in cardiac risk detection,’ the February 2026 report states. The report highlights a significant turning point for the company following FDA clearance of its 12-lead ECG synthesis software in December 2025 for arrhythmia assessment, which resolved an earlier regulatory setback and allowed HeartBeam to transition to commercial-stage status.”

Frontieras North America will host a groundbreaking ceremony on Thursday, April 2, 2026, at 11:30 a.m. ET for its first commercial FASForm(TM) facility in Mason County, West Virginia, with a livestream broadcast from Point Pleasant allowing remote audiences to participate in the milestone event. The ceremony will feature remarks from company leadership and government officials and mark the launch of an estimated $850 million project expected to create approximately 300 full-time jobs and 2,000 construction roles as the company advances commercialization of its solid carbon fractionation technology.

U.S. Energy (NASDAQ: USEG) announced the pricing of an underwritten public offering of 8.8 million shares at $1.00 per share for gross proceeds of approximately $8.8 million, with closing expected March 10, 2026, subject to customary conditions. The company said it intends to use net proceeds to fund growth capital for its industrial gas development project, including processing plant and infrastructure, as well as to support ongoing operations, with Roth Capital Partners serving as sole book-running manager.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Datavault AI (NASDAQ: DVLT) announced the closing of a definitive agreement with Coppercore Inc. to digitize and tokenize copper resources through its proprietary blockchain platform, targeting the creation of $100 million or more in Coppercoin(TM) digital tokens. Each token will represent five pounds of in-ground copper with pricing linked to COMEX benchmarks, enabling fractional, liquid ownership for global investors, as the company positions the initiative to launch by the end of the second quarter and expand access to the growing copper market tied to AI infrastructure, electrification and energy transition demand.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) acknowledged its partner Hastings Technology Metals, alongside Wyloo, for acquiring a fully permitted mixed rare earth chloride production facility in Thailand, a move expected to accelerate near-term processing of monazite feedstock and strengthen a Western-aligned rare earth supply chain. The company said the development supports ongoing discussions toward a long-term supply agreement tied to its Louisiana Strategic Metals Complex, as it works to integrate upstream supply with midstream processing and rare earth oxide production capabilities.

Telomir Pharmaceuticals (NASDAQ: TELO) announced the submission of an Investigational New Drug application to the FDA for Telomir-1 (Telomir-Zn) targeting advanced and metastatic triple-negative breast cancer, supported by preclinical efficacy and safety data demonstrating tumor growth reduction and favorable tolerability. Pending IND clearance, the company plans to initiate a Phase 1/2 clinical trial evaluating the oral therapy, with a focus on safety, dose optimization and early signs of antitumor activity, as it advances a novel epigenetic approach aimed at addressing significant unmet need in aggressive breast cancer.

Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.

NextPlat (NASDAQ: NXPL, NXPLW) reported full-year 2025 revenue of approximately $54.3 million, down 18% year over year, reflecting declines in healthcare prescription volumes partially offset by growth in e-commerce sales and higher-margin services. The company highlighted significant cost reductions, including a 50% decrease in operating expenses, improved balance sheet strength with $13.7 million in cash and no meaningful unsecured debt, and a strategic shift toward higher-margin healthcare services and expanding global e-commerce operations, positioning the business for anticipated growth and improved profitability in 2026.

Towards the end of last week, the price of copper dropped by over 1% to reach $5.43 per pound. Thus far, the red metal’s price has reduced by more than 16% from its January high. A recently conducted analysis shows that copper’s sharp price increase from last year was primarily driven more by investor activity than by underlying market fundamentals.

The war in Iran is exposing something the global energy conversation has consistently glossed over. Different countries are approaching the shift away from fossil fuels from entirely different positions, at entirely different speeds, and with entirely different consequences when disruption hits. The crisis has made those differences impossible to ignore.

Surging oil prices are reshaping buying decisions for millions of drivers, and Chinese electric vehicle manufacturers are positioned to benefit the most. Geopolitical instability across the Middle East has pushed crude oil to above $100 per barrel, unsettling fuel markets worldwide.

Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.

A team of scientists from Texas Children’s Hospital, University of Pittsburgh and Baylor College of Medicine has discovered the primary driver of a deadly pediatric brain cancer, PFA (posterior fossa type A) ependymoma. They identified male sex hormones called androgens as playing a key role in promoting PFA ependymoma growth.

The number of electric vehicles on the road is growing steadily, and this shift is beginning to affect more than just the environment. New research shows that increasing the use of electric vehicles, often called EVs, could help lower gasoline prices for everyone, including people who still drive fossil fuel-powered cars.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

Annovis Bio (NYSE: ANVS) announced the publication of an article in The Scientist detailing the discovery and development of its lead drug candidate buntanetap, as the company advances ongoing Phase 3 and extension studies in Alzheimer’s disease and Parkinson’s disease. The company said the article provides historical and scientific context for buntanetap’s progression, with current trials showing approximately 70% enrollment in early Alzheimer’s and 20% enrollment in Parkinson’s, underscoring its focus on advancing neurodegenerative therapies toward key clinical and regulatory milestones.

A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development that highlights both the potential of the therapy and the growing strength of the company’s rare disease pipeline.

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.